PM Modi will hold a meeting of the Council of Ministers today, most likely to discuss the Omicron Surge

Prime Minister Narendra Modi is holding a meeting of the Council of Ministers today, likely to discuss measures in light of the new variant, amid an alarming rise in cases of Omicron in India. Despite the fact that the PM’s office has yet to issue a statement on the subject of this meeting. The meeting will take place on Wednesday at 4 p.m., and almost all Cabinet Ministers are expected to attend.


Read Also: After Corbevax, Covovax receives a DCGI nod, bringing India’s vaccine kitty to seven

According to data from the Union Health Ministry, India has recorded 781 cases of the Omicron variant of coronavirus across 21 states and UTs so far, with 241 people recovering or migrating. Delhi had the most cases (238), followed by Maharashtra (167), Gujarat (73), Kerala (65), and Telangana (62).

The World Health Organization (WHO) warned on Tuesday that the new COVID-19 strain could overwhelm healthcare systems around the world, particularly in Europe and the United States, where infections are on the rise.

India has announced a vaccine for children as well as a ‘precaution dose’ for the elderly and healthcare workers.

Read Also: India Approves Two New Vaccines As Well As Merck’s Covid Pill

PM Modi recently announced that vaccination against COVID-19 for children aged 15 to 18 years will begin on January 3, with a “precaution dose” for healthcare and frontline workers beginning on January 10. The decisions were made in the wake of an increase in Corornavirus cases linked to the newly discovered and highly infectious Omicron variant.

In a speech to the nation on December 25, he stated that the precaution dose will be available on January 10 next year for citizens over 60 and with comorbidities on the advice of their doctor.

His speech came on the same day that officials announced that the Drugs Controller General of India (DCGI) had granted emergency use authorization to Bharat Biotech’s Covaxin, an indigenously developed vaccine, for children aged 12 and up with certain conditions. After Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D, it is the second vaccine to receive regulatory approval for use in children under the age of 18.

The number of vaccines available in India has increased to seven.

The DCGI granted emergency authorization to Novavax-Covovax SII’s on Tuesday, giving India’s vaccination programme yet another boost. Covovax, a joint venture between Novavax and the Serum Institute of India, is still awaiting FDA approval in the United States.

Read Also: Last 24 hours, India has Reported 6,358 New Covid-19 cases, with 293 Deaths Omicron has Reported 653 new cases

With this latest approval, India’s vaccine portfolio has grown to include Covishield, Covaxin, Sputnik V, Moderna vaccine (mRNA-1273), Janssen vaccine, ZyCoV-D, and Corbevax, as well as the ability to import any foreign-based vaccine, such as Pfizer.

Related Articles

Back to top button

Adblock Detected

Please close Adblocker